(Q41336798)
Statements
1 reference
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters (English)
1 reference
Hartwig Huland
1 reference
Claudia Hube-Magg
1 reference
Christina Koop
1 reference
Hans Heinzer
1 reference
Sarah Minner
1 reference
Guido Sauter
1 reference
Thorsten Schlomm
1 reference
Stefan Steurer
1 reference
Waldemar Wilczak
1 reference
Martina Kluth
1 reference
Maria Christina Tsourlakis
1 reference
Corinna Wittmer
1 reference
Nathaniel Melling
1 reference
Till Krech
1 reference
Erik Thomsen
1 reference
Markus Graefen
1 reference
Ronald Simon
1 reference
21 September 2015
1 reference
1 reference
36
1 reference
11
1 reference
1333-1340
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference